Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results

Hansa Biopharma Hosts Virtual Event with Transplant Surgeons

Hansa Biopharma AB announced a virtual event featuring distinguished transplant surgeons to discuss clinical practice and imlifidase Phase 3 results.

The event will feature Professor Robert Montgomery from NYU Langone Transplant Institute and Professor Matthew Cooper from the Medical College of Wisconsin, providing insights into the medical journey of highly sensitized patients awaiting a kidney transplant.

No direct quote available in the given text.

Author's summary: Hansa Biopharma hosts a virtual event on kidney transplant.

more

PR Newswire UK PR Newswire UK — 2025-10-29